Medtronic put up $316m for Epix Therapeutics

医疗器械巨头美敦力计划3.16亿美元收购Epix Therapeutics

2019-06-25 17:03:00 Mass Device

本文共582个字,阅读需2分钟

Medtronic  put a total of $316 million on the table to acquire Epix Therapeutics, including a $100 million earn-out. The Fridley, Minn.-based company, which is the world’s largest pure-play medical device maker, in January announced the deal for Epix, formerly known as Advanced Cardiac Therapeutics, without revealing further terms. In a regulatory filing last week, Medtronic said the milestone largely consists of “a product development-based payment triggered upon a U.S. Federal Drug Administration regulatory approval” for Santa Clara, Calif.-based Epix’s flagship DiamondTemp catheter-based radiofrequency cardiac ablation system. DiamondTemp won CE Mark approval in the European Union in 2017. The company is engaged in an FDA IDE trial of the device, the Diamond-AF trial, which it hopes will support regulatory clearance in the US with indications for treating patients with symptomatic paroxysmal atrial fibrillation. Epix added that it is also engaged in a trial, the Diamond-AF II trial, which is exploring the device’s use in treating patients with persistent AF. Late last year, Medtronic closed the $1.7 billion acquisition of Mazor Robotics (NSDQ:MZOR) and its robot-assisted surgery platform, capping the buyout with the announcement that their first jointly produced product won an FDA nod.
美敦力(Medtronic)总共拿出3.16亿美元收购 EpixTherapeutics ,其中包括1亿美元的盈利。 明尼苏达州的弗里德利。这家总部位于美国的公司是世界上最大的纯游戏医疗设备制造商。今年1月,该公司宣布了收购 Epix 的交易,之前称为 AdvancedCardic Therapeutics ,但没有透露更多条款。 在上周提交的一份监管文件中,美美敦力(Medtronic)表示,这一里程碑主要包括“一笔基于产品开发的付款,是在美国联邦药品管理局( FDA )批准加州圣克拉拉( Santa Clara )之后触发的”。基于 Epix 的旗舰 DiamondTemp 导管射频心脏消融系统。2017年, DiamondTemp 在欧盟获得 CE 标志认证。 该公司正在从事该设备的 FDA IDE 试验,即 Diamond-AF 试验,该公司希望该试验将支持美国的监管机构批准,用于治疗有症状的阵发性房颤患者。Epix 补充说,该公司还在进行一项试验,即 Diamond-AFII 试验,该试验正在探索该设备在治疗持续性房颤患者中的应用。 去年年底,美美敦力(Medtronic)以17亿美元完成了对 Mazor Robotics ( NSDQ : MZOR )及其机器人辅助手术平台的收购,并宣布他们的首个联合生产的产品获得了 FDA 的批准。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文